Literature DB >> 22796138

Incidence of acute hepatitis B in different ethnic groups in a low-endemic country, 1992-2009: increased risk in second generation migrants.

Jane Whelan1, Gerard Sonder, José Heuker, Anneke van den Hoek.   

Abstract

BACKGROUND: The Netherlands is a low-incidence country for acute hepatitis B (HBV) infection (1.2/100,000 in 2010), where it is typically acquired in adulthood through injecting drug use or homosexual exposure. Recently, the number of heterosexually acquired acute infections in the Netherlands has increased. Ethnicity may be a risk factor. We describe trends in the incidence of acute HBV among heterosexual adults in ethnic groups in Amsterdam from 1992 to 2009 and discuss future control of HBV in the Netherlands.
METHODS: We studied all cases of acute HBV acquired in heterosexuals aged ≥15 years in the Amsterdam region (1992-2009, n=238) by ethnic group. Incidence rates were estimated as the average number of cases per 100,000 per year. Using Poisson regression, we calculated univariable and multivariable incidence rate ratios (IRR) by ethnic group over calendar year, by age and gender.
RESULTS: The incidence in first generation migrants from HBV-endemic countries (FGM) was 4.1/100,000 showing no trend over time. Since 1999, incidence in Dutch-born cases in Amsterdam has increased by 13% annually from 0.2/100,000 in 1999 to 2.1/100,000 in 2009 (annual IRR 1.13, 95% CI:1.0-1.22). From 2004 to 2009, the incidence in native Dutch/Western in Amsterdam was 1.6/100,000 (reference for IRR), in FGM was 4.3/100,000 (IRR of 2.7, 95% CI:1.8-4.2) and in Dutch-born second generation migrants (SGM) was 3.7/100,000 (IRR:2.4, 95% CI:1.2-4.7).
CONCLUSION: Incidence of acute hepatitis B in Amsterdam in FGM and SGM is higher than in the native Dutch population. Low-endemic countries with migrant populations from HBV-endemic areas should consider offering screening and vaccination to both FGM and SGM.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22796138     DOI: 10.1016/j.vaccine.2012.06.080

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.

Authors:  Daniele Mipatrini; Paola Stefanelli; Santino Severoni; Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2017-02-06       Impact factor: 2.894

2.  Hepatitis B birth dose vaccination rates among children in Beijing: A comparison of local residents and first and second generation migrants.

Authors:  Ruohan Chen; Youwei Li; Knut Reidar Wangen; Stephen Nicholas; Elizabeth Maitland; Jian Wang
Journal:  Hum Vaccin Immunother       Date:  2016-04-04       Impact factor: 3.452

3.  Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users.

Authors:  Fabio Lugoboni; Raimondo Maria Pavarin; Chiara Resentera; Daniele Gambini
Journal:  Int J Environ Res Public Health       Date:  2015-04-13       Impact factor: 3.390

4.  Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium.

Authors:  Özgür M Koc; Cécile Kremer; Niel Hens; Rob Bielen; Dana Busschots; Pierre Van Damme; Geert Robaeys
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

5.  Vaccine completion and infectious diseases screening in a cohort of adult refugees following resettlement in the U.S.: 2013-2015.

Authors:  Amir M Mohareb; Bryan Brown; Kevin S Ikuta; Emily P Hyle; Aniyizhai Annamalai
Journal:  BMC Infect Dis       Date:  2021-06-16       Impact factor: 3.090

6.  Dried blood spot sampling for hepatitis B virus serology and molecular testing.

Authors:  Sofiane Mohamed; Audrey Raimondo; Guillaume Pénaranda; Claire Camus; Denis Ouzan; Sophie Ravet; Marc Bourlière; Hacène Khiri; Patrick Dukan; Daniel Olive; Philippe Halfon
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.